Please contact me at 
brosebe...@cartermackay.com<mailto:brosebe...@cartermackay.com> for more 
information on the below role:
The Senior Scientist will collaborate with team members to identify and define 
mechanisms of action, biomarkers and new drug targets. They will help design 
clinical pharmacology trials and selecting pharmacokinetic (PK)/pharmacodynamic 
(PD) /biomarker assessments throughout development, develop 
physiologically-based pharmacokinetic (PB-PK) models, evaluate new formulations 
effect on PK. Will conduct PK/PD analysis and reporting, contribute relevant 
sections to regulatory filings, work with pharmacometricians to develop PK/PD 
models and contribute to commercial strategies.

Key responsibilities
*             Contribute to the development and execution of Clinical 
Pharmacology strategy for given programs
*             Collaborate with clinical development to design and implement 
early clinical development strategies (first-in-man through  proof of concept 
Phase Ib/Phase 2a)
*             Identify new drug targets and biomarkers
*             Work on development of physiologically-based pharmacokinetic 
models
*             responsible for the generation of protocol outlines
*             Coordinate with bioanalytical scientists on types methods used to 
support clinical trials.
*             Analyze PK and PD data using non-compartmental and compartmental 
methods
prepares PK and PD sections of study reports and regulatory submissions 
documents.
*             Partner with pharmacometricians to develop PK/PD/efficacy models.
*             represent the PK function at internal and external meetings
Qualifications

*             PhD or PharmD
*             Minimum of 2-5 years PK/PD experience  (can include postdoc work)
*             Able to work with minimal supervision and think independently
*             Has demonstrated success in technical proficiency, scientific 
creativity and collaboration with others.
*             Has worked on problems in which analysis of data requires 
evaluation of identifiable factors
*             Solid understanding of clinical pharmacology with knowledge of 
PK/drug metabolism and human physiology
*             Ability to create written summaries and presentations using MS 
Office (Word, Excel, PowerPoint, Outlook) and Sigma Plot
*             Experience with PK/PD software (e.g., WinNonlin) and plotting 
software (e.g., R, SigmaPlot,





[cid:1.1213385771@web31815.mail.mud.yahoo.com]
Brenda Roseberry
   Division Manager-Scientific
   Preclinical/Clinical--PK, Pharmacology, Pharmacometrics, Biomarkers
    720-328-9526 - Office
    315-415-4353 -  Mobile
    720-475-1176 - Fax
   [cid:image001.png@01CBC1F8.25033B10] 
<http://www.linkedin.com/profile/view?id=19937880&authType=name&authToken=b5d_>

Reply via email to